Press Releases

Media Room

CollPlant expands European sales network: The Company has signed a distribution agreement in the Netherlands for Vergenix®FG for treatment of acute and chronic wounds and surgical cuts

08-16-2017

CollPlant enters the wound-healing market in Israel: Treatments using the wound-healing product have started in a large clinic in the center of the country

07/17/2017

CollPlant Extends its European Distribution Network with Signing of new Distribution Agreement in Turkey for Vergenix®FG Wound Treatment

05/21/2017

CollPlant Reports Positive Results from Post-Marketing Surveillance of Vergenix®FG

04/11/2017

CollPlant Provides Commercial and Operational Update

03/30/2017

CollPlant Signs Exclusive Distribution Agreement with Arthrex for Vergenix™STR

11/8/2016

CollPlant receives CE Mark for Vergenix™STR for Treatment of Tendinopathy

10/19/2016

CollPlant Reports Positive Final Extended Clinical Trial Results with Vergenix™STR for Treatment of Tendinopathy

08/17/2016

CollPlant announces Commencement of Commercial Treatments of Vergenix®FG Wound Filler in Europe

08/10/2016

CollPlant Reaches Commercial Milestone: Company Signs distribution agreement in Italy for Vergenix®FG Wound Care Product

02/06/2016

CollPlant receives CE Mark for Vergenix™ FG Wound Filler

02/23/2016

CollPlant Reports Positive Final Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

02/04/2016

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, Indicated for the Treatment of Tendinopathy

12/08/2015

CollPlant Reports Positive Final Trial Results For Vergenix®FG Wound Filler

11/30/2015

CollPlant Raises USD 2.2 Million in Private Placement Transaction

11/23/2015

CollPlant Announces Completion of Patient Recruitment for Clinical Trial of Vergenix™FG (Flowable Gel), for the Treatment of Chronic Wounds

10/8/2015

Approval of significant patent in Europe

8/9/2015

CollPlant Announces Submission of CE Technical File for VergenixTMFG and Successful Complementary Interim Clinical Results

8/5/2015

CollPlant Names Shomrat Shurtz Senior Director of Business Development

7/28/2015

CollPlant Reports Positive Interim Trial Results for Vergenix™STR, for the Treatment of Tendinopathy

7/20/2015

CollPlant Executes Non-binding Term Sheet to Develop and Commercialize a Novel Product for Spinal Fusion and Trauma Indications in Collaboration with Leading US Partner

7/12/2015

CollPlant share holders meeting

6/24/2015

CollPlant Reports Positive Interim Trial Results for Vergenix®FG Wound Healing Gel

3/19/2015

Trials for Vergenix®STR Have Begun – a Human Collagen-based Product for Tendon Repair

1/16/2015

CollPlant share holders meeting

1/14/2015

Collplant launched a clinical trial with Vergenix ®FG

12/7/2014

CollPlant Holds Intellectual Property Rights in USA

7/1/2014

CollPlant takes a step closer to commercializing its product for treating wounds

6/19/2014

CollPlant share holders meeting

12/22/2013

CollPlant successfully completed a wound closure clinical study and fully achieved its obective.

8/7/2012

CollPlant to develop orthopedic product with Pfizer

12/25/2011

CollPlant receives quality assurance certification for medical devices

7/4/2012

® 2015 CollPlant Ltd. All rights reserved. Version: CPW 02-16